Off-label treatment in diabetic retinopathy
DOI:
https://doi.org/10.9771/cmbio.v13i1.9024Palavras-chave:
Diabetic retinopathy. Off-label use. Therapy. Diabetes mellitus.Resumo
Introduction: The prescribing a drug without the indications for which the drug was originally approved by regulators is internationally known as prescribing “off-label”. Objective: To describe the off-label therapy in diabetic retinopathy, reported international scientific literature, through an integrative bibliographical review. Method: Integrative review by searching the Medline international database for review of manuscripts. Results: A total 852 scientific productions were identified, and 37 studies were selected by contain information about the off-label therapy in diabetic retinopathy. Conclusion: The practice of off-label prescribing in diabetic retinopathy has benefits, and in some situations is the only treatment available.
Downloads
Downloads
Publicado
Como Citar
Edição
Seção
Licença
A Revista de Ciências Médicas e Biológicas reserva-se todos os direitos autorais dos trabalhos publicados, inclusive de tradução, permitindo, entretanto, a sua posterior reprodução como transcrição, com a devida citação de fonte. O periódico tem acesso livre e gratuito.